Sestrin1, 2, and 3 are dispensable for female fertility in mice
- PMID: 38297375
- PMCID: PMC10832176
- DOI: 10.1186/s13048-024-01345-z
Sestrin1, 2, and 3 are dispensable for female fertility in mice
Abstract
Background: Sestrins have been implicated in regulating aging in various organs through multiple pathways. However, their roles in ovarian aging remain unrevealed.
Methods: Female Sestrin1-/-, Sestrin2-/-, and Sestrin3-/- mice were generated using the CRISPR-Cas9 system. Body weights, little sizes, ovarian weights, estrous cyclicity, and follicle number in female mice were observed. ELISA was utilized to measure serum anti-Müllerian hormone (AMH) levels. Real time PCR, western blot, immunofluorescence, and Masson trichrome staining were employed for assessment of aging-related change.
Results: The deletion of Sestrin 1, 2, or 3 had no discernible impact on body weights,or serum AMH levels in female mice at the age of 12 months. And there were no discernible differences in litter sizes or estrous cyclicity which were assessed at the age of 8 months. At the age of 12 months, no significant differences were observed in ovarian weights or follicle numbers among the knockout mice. Consistently, the extent of fibrosis within the ovaries remained comparable across all experimental groups at this age. Additionally, autophagy, apoptosis, DNA damage, and inflammation within the ovaries were also found to be comparable to those in wild-type mice of the same age.
Conclusions: The loss of Sestrin 1, 2, or 3 does not exert a noticeable influence on ovarian function during the aging process. Sestrin1, 2, and 3 are not essential for female fertility in mice.
Keywords: Female fertility; Ovarian aging; Sestrin1; Sestrin2; Sestrin3.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10832176/bin/13048_2024_1345_Fig1_HTML.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10832176/bin/13048_2024_1345_Fig2_HTML.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10832176/bin/13048_2024_1345_Fig3_HTML.gif)
![Fig. 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10832176/bin/13048_2024_1345_Fig4_HTML.gif)
Similar articles
-
Dual suppression of follicle activation pathways completely prevents the cyclophosphamide-induced loss of ovarian reserve.Hum Reprod. 2023 Jun 1;38(6):1086-1098. doi: 10.1093/humrep/dead064. Hum Reprod. 2023. PMID: 37015102
-
Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.Hum Reprod. 2018 May 1;33(5):844-859. doi: 10.1093/humrep/dey045. Hum Reprod. 2018. PMID: 29534229
-
A putative role for anti-Müllerian hormone (AMH) in optimising ovarian reserve expenditure.J Endocrinol. 2017 Apr;233(1):R1-R13. doi: 10.1530/JOE-16-0522. Epub 2017 Jan 27. J Endocrinol. 2017. PMID: 28130407 Review.
-
Protective effects and mechanisms investigation of Kuntai capsule on the ovarian function of a novel model with accelerated aging ovaries.J Ethnopharmacol. 2017 Jan 4;195:173-181. doi: 10.1016/j.jep.2016.11.014. Epub 2016 Nov 11. J Ethnopharmacol. 2017. PMID: 27845267
-
The physiology and clinical utility of anti-Mullerian hormone in women.Hum Reprod Update. 2014 May-Jun;20(3):370-85. doi: 10.1093/humupd/dmt062. Epub 2014 Jan 14. Hum Reprod Update. 2014. PMID: 24430863 Review.
References
-
- Liu X, Mai H, Chen P, Zhang Z, Wu T, Chen J, Sun P, Zhou C, Liang X, Huang R. Comparative analyses in transcriptome of human granulosa cells and follicular fluid micro-environment between poor ovarian responders with conventional controlled ovarian or mild ovarian stimulations. Reprod Biol Endocrinol. 2022;20(1):54. doi: 10.1186/s12958-022-00926-1. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources